20 results
DEFA14A
ISEE
IVERIC bio Inc
20 Jun 23
Additional proxy soliciting materials
9:06am
allegations. Nothing in these supplemental disclosures shall be deemed an admission of liability or the legal necessity or materiality under applicable
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
to specified materiality standards;
IVERIC, Parent and Merger Sub having performed in all material respects their respective obligations under … Agreement. The representations and warranties may also be subject to a contractual standard of materiality different from those generally applicable
PREM14A
ISEE
IVERIC bio Inc
23 May 23
Preliminary proxy related to merger
6:49am
and Merger Sub in the Merger Agreement, subject to specified materiality standards;
IVERIC, Parent and Merger Sub having performed in all material respects … Agreement. The representations and warranties may also be subject to a contractual standard of materiality different from those generally applicable
DEFA14A
ISEE
IVERIC bio Inc
1 May 23
Additional proxy soliciting materials
7:05am
delivered in connection with the Merger Agreement, (iii) are subject to materiality qualifications contained in the Merger Agreement which may differ from
DEFA14A
EX-2.1
sj17 pu0ku5ry8wva
1 May 23
Additional proxy soliciting materials
7:05am
8-K
EX-2.1
yb6102 ezld0c4ab4uh
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
9dbtdeb5he5ugfr
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
ycrqee66 9iho0
28 Sep 22
Regulation FD Disclosure
4:04pm
8-K
cetxnyjg
5 Jul 22
Entry into a Material Definitive Agreement
7:36am
S-3ASR
EX-5.1
obbf6unv 0yiiz
21 Oct 21
Automatic shelf registration
4:01pm
8-K
uwyehxllxn3r9rjdcb9f
14 Aug 19
Regulation FD Disclosure
12:00am
8-K
ny4dye2vh4bvnv5r2
7 Jan 19
Results of Operations and Financial Condition
7:59am
8-K
9w8lrz2x3ez
31 Oct 18
Ophthotech Expands Innovative Retinal Disease Pipeline With Acquisition of Versant Ventures’ Inception 4
6:46am
8-K
EX-2.1
7in21 jt6lb7lt1nd
31 Oct 18
Ophthotech Expands Innovative Retinal Disease Pipeline With Acquisition of Versant Ventures’ Inception 4
6:46am
S-3
EX-1.2
qkanb0y
1 Aug 18
Shelf registration
4:42pm
S-3
EX-5.1
rc16srj go9f987jur
1 Aug 18
Shelf registration
4:42pm
- Prev
- 1
- Next